ArticleMalaria journal2014
Malaria treatment policy change in Uganda: what role did evidence play?
Article in Malaria journal, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- Towards equitable partnerships in global health research: experiences from Ethiopia, Uganda, Lao PDR and Vietnam.BMJ global health · 2025Article
- A review of efficacy and safety of Ugandan anti-malarial plants with application of RITAM score.Malaria journal · 2023Review
- The Role of Community Participation in Planning and Executing Malaria Interventions: Experience from Implementation of Biolarviciding for Malaria Vector Control in Southern Tanzania.BioMed research international · 2022Article
- Opening the policy blackbox: unravelling the process for changing national diagnostic and treatment guidelines for vivax malaria in seven countries.Malaria journal · 2021Article
- Rolling out the radical cure for vivax malaria in Asia: a qualitative study among policy makers and stakeholders.Malaria journal · 2021Article
- A scoping review of the uses and institutionalisation of knowledge for health policy in low- and middle-income countries.Health research policy and systems · 2020Article
- Organisational factors that facilitate research use in public health policy-making: a scoping review.Health research policy and systems · 2019Article
- Strengthening national health research systems in the WHO African Region - progress towards universal health coverage.Globalization and health · 2019Article
- Private sector drug shops frequently dispense parenteral anti-malarials in a rural region of Western Uganda.Malaria journal · 2018Article
- The Burden of Adverse Drug Reactions Due to Artemisinin-Based Antimalarial Treatment in Selected Ugandan Health Facilities: An Active Follow-Up Study.Drug safety · 2018Observational
- Knowledge translation for public health in low- and middle- income countries: a critical interpretive synthesis.Global health research and policy · 2018Review
- Harmonisation and standardisation of health sector and programme reviews and evaluations - how can they better inform health policy dialogue?Health research policy and systems · 2016Article
- Health worker perspectives on the possible use of intramuscular artesunate for the treatment of severe malaria at lower-level health facilities in settings with poor access to referral facilities in Nigeria: a qualitative study.BMC health services research · 2016Article
- Global Forum 2015 dialogue on "From evidence to policy - thinking outside the box": perspectives to improve evidence uptake and good practices in the African Region.BMC health services research · 2016Article
- National malaria vector control policy: an analysis of the decision to scale-up larviciding in Nigeria.Health policy and planning · 2016Article
- 'Better medicines for children' within the Integrated Management of Childhood Illness framework: a qualitative inquiry in Uganda.Journal of pharmaceutical policy and practice · 2016Article
- The past, present and future use of epidemiological intelligence to plan malaria vector control and parasite prevention in Uganda.Malaria journal · 2015Review
- Explaining the slow transition of child-appropriate dosage formulations from the global to national level in the context of Uganda: a qualitative study.Journal of pharmaceutical policy and practice · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundAlthough increasing attention is being paid to knowledge translation (KT), research findings are not being utilized to the desired extent. The present study explores the role of evidence, barriers, and factors facilitating the uptake of evidence in the change in malaria treatment policy in Uganda, building on previous work in Uganda that led to the development of a middle range theory (MRT) outlining the main facilitatory factors for KT. Application of the MRT to a health policy case will contribute to refining it.
methodsUsing a case study approach and mixed methods, perceptions of respondents on whether evidence was available, had been considered and barriers and facilitatory factors to the uptake of evidence were explored. In addition, the respondents' rating of the degree of consistency between the policy decision and available evidence was assessed. Data collection methods included key informant interviews and document review. Qualitative data were analysed using content thematic analysis, whereas quantitative data were analysed using Excel spreadsheets. The two data sets were eventually triangulated.
resultsEvidence was used to change the malaria treatment policy, though the consistency between evidence and policy decisions varied along the policy development cycle. The availability of high-quality and contextualized evidence, including effective dissemination, Ministry of Health institutional capacity to lead the KT process, intervention of the WHO and a regional professional network, the existence of partnerships for KT with mutual trust and availability of funding, tools, and inputs to implement evidence, were the most important facilitatory factors that enhanced the uptake of evidence. Among the barriers that had to be overcome were resistance from implementers, the health system capacity to implement evidence, and financial sustainability.
conclusionThe results agree with facilitatory factors identified in the earlier developed MRT, though additional factors emerged. These results refine the earlier MRT stating that high-quality and contextualized evidence will be taken up in policies, leading to evidence-informed policies when the MoH leads the KT process, partnerships are in place for KT, the WHO and regional professional bodies play a role, and funding, tools, and required inputs for implementing evidence are available.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.